Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study.

Ballantyne, Christie M; Manku, Mehar S; Bays, Harold E; Philip, Sephy; Granowitz, Craig; Doyle, Ralph T; Juliano, Rebecca A

Ballantyne, Christie M; Manku, Mehar S; Bays, Harold E; Philip, Sephy; Granowitz, Craig; Doyle, Ralph T; Juliano, Rebecca A.

Afiliação

Ballantyne CM; Department of Medicine, Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. cmb@bcm.tmc.edu.
Manku MS; Amarin Pharma Inc, Bedminster, NJ, USA.
Bays HE; Clinical Research, Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA.
Philip S; Medical Affairs, Amarin Pharma Inc, Bedminster, NJ, USA.
Granowitz C; Medical Affairs, Amarin Pharma Inc, Bedminster, NJ, USA.
Doyle RT; Research and Development, Amarin Pharma Inc, Bedminster, NJ, USA.
Juliano RA; Research and Development, Amarin Pharma Inc, Bedminster, NJ, USA.

Cardiol Ther ; 8(1): 79-90, 2019 Jun.

Article em En | MEDLINE | ID: mdl-30788718

Palavras-chave

Arachidonic acid; Eicosapentaenoic acid; Fatty acids; Hypertriglyceridemia; Icosapent ethyl; Omega-3 fatty acids; Omega-6 fatty acids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos